According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere News item 26 January 2013 Pages: 2 - 2
The American Heart Association (AHA) has announced updated guidelines Media release 26 January 2013 Pages: 3 - 3
Teenagers presenting for pregnancy termination are “no less responsible about contraceptive use” Clinical study 26 January 2013 Pages: 4 - 4
Influenza virus vaccine uptake is low among healthcare workers in Victoria, Australia, Clinical study 26 January 2013 Pages: 4 - 4
Voriconazole best value for invasive aspergillosis in Spain Clinical study 26 January 2013 Pages: 5 - 5
Rizatriptan, eletriptan most cost-effective oral triptans for migraine? Clinical study 26 January 2013 Pages: 5 - 5
Many patients with DM missing lipid targets, missing treatment Clinical study 26 January 2013 Pages: 7 - 7
Use of atorvastatin increases following PROVE-IT, REVERSAL Clinical study 26 January 2013 Pages: 7 - 7
Antithrombotics are prescribed to most outpatients with permanent atrial fibrillation (AF), however the use of vitamin K antagonists decreases with age. Clinical study 26 January 2013 Pages: 7 - 7
Nosocomial neonatal candidaemia increases hospital costs Non-clinical study 26 January 2013 Pages: 7 - 7
Clinical prescribing and the secondary prevention of PTSD Clinical study 26 January 2013 Pages: 8 - 8
Hyperlipidaemia frequently undertreated after ED visits for ACS Clinical study 26 January 2013 Pages: 8 - 8
Economics of expanded hepatitis A vaccination “reasonable” Clinical study 26 January 2013 Pages: 8 - 8
The Russian government has granted approval for a federal programme News item 26 January 2013 Pages: 10 - 10
The Australian government is to allocate approximately $A70 million* to community pharmacies News item 26 January 2013 Pages: 10 - 10
A “full and far reaching” plan has been introduced by the South African government News item 26 January 2013 Pages: 11 - 11
WHO has issued new guidance calling for the introduction of pneumococcal conjugate vaccines into immunisation programmes for developing countries. Media release 26 January 2013 Pages: 11 - 11
Sanofi-aventis has announced that its cannabinoid 1 receptor antagonist, Acomplia [rimonabant], Media release 26 January 2013 Pages: 11 - 11
Japan has announced a new contribution of $US186 million Media release 26 January 2013 Pages: 11 - 11